ASXL1 (D1B6V) Rabbit Monoclonal Antibody#52519,Cell Signaling Technology (CST),52519

ASXL1 (D1B6V) Rabbit Monoclonal Antibody recognizes endogenous levels of total ASXL1 protein.

Host

Rabbit

Reactivity

Human, Mouse, Rat, Monkey

Application

Western Blotting: 1:1000

Platform ID

BAB276745243

Cell Signaling Technology (CST)

Headquarters

3 Trask Lane Danvers, MA 01923

Contact

Tel: 877-616-2355,978-867-2388
Fax: 877-616-2355

Product Specifications
Scientific Background
Synonyms

Specifications

NameASXL1 (D1B6V) Rabbit Monoclonal Antibody#52519
Cat. No.52519
Accession NumberQ8IXJ9, 171023
Gene ID (Entrez)171023
HostRabbit
SensitivityEndogenous
ReactivityHuman, Mouse, Rat, Monkey
ApplicationWestern Blotting: 1:1000
Molecular Weight250
ImmunogenIgG
FormulationSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.
StorageSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.
Regulatory StatusResearch Use Only

Scientific Background

Additional sex combs-like protein 1 (ASXL1) is a polycomb-associated protein that interacts with polycomb repressive complex 2 (PRC2), which contains the histone methyltransferase EZH2 and functions to mono-, di-, and tri-methylate histone H3 on lysine 27. These histone marks are associated with transcriptional repression (1). In addition, ASXL1 interacts with BRCA1-associated protein 1 (BAP1), the catalytic subunit of the polycomb repressive deubiquitinase complex (PR-DUB), which functions to de-ubiquitinate histone H2A at lysine 119 and activate transcription (2). ASXL1 functions as a transcriptional regulator of adipogenesis, acting to repress peroxisome proliferator-activated receptor gamma (PPARG) adipocyte differentiation. ASXL1 also functions as a transcriptional regulator of hematopoiesis acting as an activator of retinoic acid receptor (RAR) mediated transcriptional activation (3,4). ASXL1 is mutated or deleted in 10 to 30 percent of all myeloid malignancies, with loss-of-function mutations associated with poor prognosis in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Hematopoietic-specific deletions of ASXL1 in mice result in progressive, multi-lineage cytopenias and dysplasias, leading to increased number of hematopoietic stem and progenitor cells (5).Abdel-Wahab, O. et al. (2012)Cancer Cell22, 180-93.Scheuermann, J.C. et al. (2010)Nature465, 243-7.Park, U.H. et al. (2011)J Biol Chem286, 1354-63.Cho, Y.S. et al. (2006)J Biol Chem281, 17588-98.Abdel-Wahab, O. et al. (2013)J Exp Med210, 2641-59.Alternate Namesadditional sex combs like 1 (Drosophila); additional sex combs like 1, transcriptional regulator; additional sex combs like transcriptional regulator 1; Additional sex combs-like protein 1; ASXL transcriptional regulator 1; ASXL1; BOPS; KIAA0978; MDS; MGC117280; MGC71111; Polycomb group protein ASXL1; Putative Polycomb group protein ASXL1

Synonyms

additional sex combs like 1 (Drosophila); additional sex combs like 1, transcriptional regulator; additional sex combs like transcriptional regulator 1; Additional sex combs-like protein 1; ASXL transcriptional regulator 1; ASXL1; BOPS; KIAA0978; MDS; MGC117280; MGC71111; Polycomb group protein ASXL1; Putative Polycomb group protein ASXL1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.